DescriptionCurator's Comment: description was created based on several sources, including:
DOI: 10.1042/bj0280143
DOI: 10.1042/bj0280152
http://www.wikidoc.org/index.php/Glycerol_3-phosphate
Curator's Comment: description was created based on several sources, including:
DOI: 10.1042/bj0280143
DOI: 10.1042/bj0280152
http://www.wikidoc.org/index.php/Glycerol_3-phosphate
Synthetic glycerophosphates have been known for many years and have been prepared in several ways. The acid may exist in two isomeric forms, alpha and beta. The L-a-acid is the naturally occurring form; the b-acid, present in hydrolyzates of lecithins from natural sources, arises from migration of the phosphoryl group from the a-carbon atom. Dehydrogenation of L-glycerol 3-phosphate produces Dihydroxyacetone phosphate and is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway.
CNS Activity
Originator
Curator's Comment: alpha-glycerophosphoric acid has long been known as a component of the lecithins and cephalins and may in a sense be looked on as a monoglyceride, the situation is much more favorable. Because of its great stability it has been possible for several workers to separate it from various phosphatides and free it from its accompanying beta-isomer. http://www.jbc.org/content/128/2/491.short
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: 2819.0 Gene Symbol: GPD1 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | KABIVEN Approved UseIt is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. Launch Date2014 |
Sample Use Guides
19 to 38 mL/kg/day. The maximum infusion rate is 2.6 mL/kg/hour. Recommended infusion period is 12 to 24 hours.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7492326
Maximal ATP production in the presence of Ca2+ (200 nM) is obtained at 10 mM L-glycerol 3-phosphate in intact mitochondria from pancreatic B-cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
4342 (Number of products:27)
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
||
|
NCI_THESAURUS |
C29730
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
||
|
WHO-ATC |
B05XA14
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
||
|
WHO-VATC |
QB05XA14
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB09561
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY | |||
|
RCS9EQ01V4
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
PRIMARY | |||
|
1318
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
PRIMARY | |||
|
1595589
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL3040581
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY | |||
|
55073-41-1
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY | |||
|
RCS9EQ01V4
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY | |||
|
YY-144
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
PRIMARY | |||
|
C120561
Created by
admin on Sat Dec 16 20:08:48 GMT 2023 , Edited by admin on Sat Dec 16 20:08:48 GMT 2023
|
PRIMARY | |||
|
SUB15289MIG
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY | |||
|
SUB90005
Created by
admin on Sat Dec 16 20:08:47 GMT 2023 , Edited by admin on Sat Dec 16 20:08:47 GMT 2023
|
PRIMARY |
All of the following components must be present:
SUBSTANCE RECORD